
-
Heat humble Celtics for sixth straight win, Thunder roll on
-
Trump escalates trade war with sweeping global tariffs
-
Japan says US tariffs 'extremely regrettable', may break WTO rules
-
South Koreans anxious, angry as court to rule on impeached president
-
Juve at in-form Roma with Champions League in the balance
-
Injuries put undermanned Bayern's title bid to the test
-
Ovechkin scores 892nd goal -- three away from Gretzky's NHL record
-
Australian former rugby star Petaia signs for NFL's Chargers
-
China says opposes new US tariffs, vows 'countermeasures'
-
Athletics world watching as 'Grand Slam Track' prepares for launch
-
Heat humble Celtics for sixth straight win, Cavs top Knicks
-
Quake-hit Myanmar's junta chief to head to Bangkok summit
-
New Spielberg, Nolan films teased at CinemaCon
-
Shaken NATO allies to meet Trump's top diplomat
-
Israel's Netanyahu arrives in Hungary, defying ICC warrant
-
Shiny and deadly, unexploded munitions a threat to Gaza children
-
Stocks tank, havens rally as Trump tariffs fan trade war
-
Altomare hangs on to tie defending champ Korda at LPGA Match Play
-
Paraguay gold rush leaves tea producers bitter
-
Health concerns swirl as Bolivian city drowns in rubbish
-
Syria says deadly Israeli strikes a 'blatant violation'
-
Financial markets tumble after Trump tariff announcement
-
Starbucks faces new hot spill lawsuits weeks after $50mn ruling
-
Europe riled, but plans cool-headed response to Trump's tariffs
-
'Shenmue' voted most influential video game ever in UK poll
-
New coal capacity hit 20-year low in 2024: report
-
Revealed: Why monkeys are better at yodelling than humans
-
Key details on Trump's market-shaking tariffs
-
'A little tough love': Top quotes from Trump tariff talk
-
US business groups voice dismay at Trump's new tariffs
-
Grealish dedicates Man City goal to late brother
-
US tariffs take aim everywhere, including uninhabited islands
-
Trump sparks trade war with sweeping global tariffs
-
Israeli strikes hit Damascus, central Syria; monitor says 4 dead
-
Slot 'hates' offside rule that gave Liverpool win over Everton
-
US stocks end up, but volatility ahead after latest Trump tariffs
-
Barca oust Atletico to set up Clasico Copa del Rey final
-
Mourinho grabs Galatasaray coach's face after losing Istanbul derby
-
Grealish strikes early as Man City move up to fourth in Premier League
-
Reims edge out fourth-tier Cannes to set up PSG French Cup final
-
Liverpool beat Everton as title looms, Man City win without Haaland
-
Jota wins bad-tempered derby as Liverpool move 12 points clear
-
Inter and Milan level in derby Italian Cup semi
-
Stuttgart beat Leipzig to reach German Cup final
-
Trump unveils sweeping global tariffs
-
Italian director Nanni Moretti in hospital after heart attack: media
-
LIV Golf stars playing at Doral with Masters on their minds
-
Trump unveils sweeping 'Liberation Day' tariffs
-
Most deadly 2024 hurricane names retired from use: UN agency
-
Boeing chief reports progress to Senate panel after 'serious missteps'

Katalin Kariko, scientific maverick who paved way for mRNA vaccines
Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.
Now, her pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.
Kariko, 68, spent much of the 1990s writing grant applications to fund her research into "messenger ribonucleic acid" -- genetic molecules that tell cells what proteins to make, essential to keeping our bodies alive and healthy.
She believed mRNA held the key to treating diseases where having more of the right kind of protein can help -- like repairing the brain after a stroke.
But the University of Pennsylvania, where Kariko was on track for a professorship, decided to pull the plug after the grant rejections piled up.
"I was up for promotion, and then they just demoted me and expected that I would walk out the door," she told AFP in an interview from her home in Philadelphia in December 2020.
Kariko didn't yet have a green card and needed a job to renew her visa. She also knew she wouldn't be able to put her daughter through college without the hefty staff discount.
She decided to persist as a lower-rung researcher, scraping by on a meagre salary.
It was a low point in her life and career, but "I just thought...you know, the (lab) bench is here, I just have to do better experiments," she said.
The determination runs in the family -- her daughter Susan Francia did go to UPenn, where she earned a master's degree, and won gold medals with the US Olympic rowing team in 2008 and 2012.
- Twin breakthroughs -
By the late 1980s, much of the scientific community was focused on using DNA to deliver gene therapy, but Kariko believed that mRNA was also promising since most diseases are not hereditary and don't need solutions that permanently alter our genetics.
First though, she had to overcome a major problem: in animal experiments, synthetic mRNA was causing a massive inflammatory response as the immune system sensed an invader and rushed to fight it.
Kariko, together with her main collaborator and co-winner Drew Weissman, discovered that one of the four building blocks of the synthetic mRNA was at fault -- and they could overcome the problem by swapping it out with a modified version.
They published a paper on the breakthrough in 2005. Then, in 2015, they found a new way to deliver mRNA into mice, using a fatty coating called "lipid nanoparticles" that prevent the mRNA from degrading, and help place it inside the right part of cells.
Both these innovations were key to the Covid-19 vaccines developed by Pfizer and its German partner BioNTech, where Kariko is now a senior vice president, as well as the shots produced by Moderna.
Both work by giving human cells the instructions to make a surface protein of the coronavirus, which simulates an infection and trains the immune system for when it encounters the real virus.
- New treatments -
Though she does not want to make too much of it, as a foreign-born woman in a male-dominated field, Kariko occasionally felt underestimated -- saying people would approach after lectures and ask "Who's your supervisor?"
"They were always thinking, 'That woman with the accent, there must be somebody behind her who is smarter or something,'" she said.
Yet the Nobel is just the latest accolade for Kariko, who has won the Breakthrough Prize, the L'Oreal-UNESCO prize for women in science awards, among many others.
It is a far cry from the time when her late mother would call every year after prize announcements to ask why she hadn't been chosen.
"I never in my life get (federal) grants, I am nobody, not even faculty," she would reply with a laugh.
To which her mother would reply: "But you work so hard!"
P.Costa--AMWN